Autres langues Aprogen Biologics Inc.

Actions

A003060

KR7003060001

Produits pharmaceutiques

Cours en clôture Korea S.E. 08/10/2026			Varia. 5j.	Varia. 1 janv.
1 544,00 ^KRW	+0,26%		-0,26%	-80,17%

13/08	Aprogen Biologics Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
14/05	Aprogen Biologics Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

23/09	Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc.
03/09	Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc.
13/08	Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
01/07	Aprogen Biologics Inc. announced that it has received KRW 50.8 billion in funding from APTOCROM Inc.
29/05	Aprogen Biologics Inc. announced that it has received KRW 10 billion in funding from Aprogen, Inc.
21/05	Aprogen Biologics Inc. announced that it expects to receive KRW 10 billion in funding from Aprogen, Inc.
14/05	Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Aprogen Biologics Inc. announced that it has received KRW 2.000001375 billion in funding from Aprogen, Inc.
13/04	Aprogen Biologics Inc. announced that it expects to receive KRW 2.000001375 billion in funding from Aprogen, Inc.
20/03	Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
13/11	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
24/10/25	Aprogen Biologics Inc. announced that it has received KRW 15 billion in funding from APTN Inc.
16/10/25	Aprogen Biologics Inc. announced that it expects to receive KRW 15 billion in funding from APTN Inc.
13/08/25	Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
22/05/25	Aprogen Medicines Inc. agreed to acquire an additional 20.06% stake in AP Healthcare Inc. from Aprogen Biologics Inc. for KRW 58.4 billion.
14/05/25	Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
27/03/25	Aprogen Biologics Inc. announced that it has received KRW 65 billion in funding from APT Neuroscience, Inc.
26/03/25	Aprogen Biologics Inc. announced that it expects to receive KRW 65 billion in funding from APT Neuroscience, Inc.
14/03/25	Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
13/11/24	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
14/08/24	Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
01/08/24	Aprogen Biologics Inc. announced that it has received KRW 70.000000384 billion in funding from Aprogen Medicines Inc.
23/07/24	An undisclosed buyer agreed to acquire 6.87% stake in Aprogen Biologics Inc. from Aprogen Medicines Inc. for KRW 43.9 billion.
04/07/24	Aprogen Biologics Inc. announced that it expects to receive KRW 70.000000384 billion in funding from Aprogen Medicines Inc.
14/05/24	Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024